News
Jascayd reinforces combination therapy shift in US pulmonary fibrosis treatment
2+ day, 9+ hour ago (126+ words) New US subgroup data for German pharma major Boehringer Ingelheim's Jascayd (nerandomilast) in idiopathic and progressive pulmonary fibrosis (IPF/PPF) is reinforcing the industry shift toward combination antifibrotic therapy in fibrotic lung disease management. This article is accessible to registered…...
China's new therapy law has a loophole western biotech missed
2+ day, 7+ hour ago (121+ words) An Expert View from Boyang Wang, the founder and managing partner of Immortal Dragons, a purpose-driven longevity fund based in Singapore focused on advancing life-extension and rejuvenation biotechnology. This article is accessible to registered users, to continue reading please register…...
Jeffery Taubenberger steps down as acting head of NIH infectious diseases institute
2+ day, 9+ hour ago (125+ words) Jeffery Taubenberger, the acting director of the US National Institute of Allergy and Infectious Diseases (NIAID), has stepped down from the role, according to reports citing congressional Democrats and sources familiar with the matter. This article is accessible to registered…...
Ebola outbreak exposes vaccine gap for rare virus strain
2+ day, 12+ hour ago (132+ words) Healthcare intelligence firm Global Data says the latest Ebola outbreak in the Democratic Republic of the Congo and Uganda is exposing a major weakness in the world's preparedness for rare viral strains, despite years of investment in Ebola vaccines and…...
BMS expands AI push with Anthropic partnership
3+ day, 12+ hour ago (91+ words) This article is accessible to registered users, to continue reading please register for free." A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a…...
Amgen announces CFO Peter Griffith retiring
4+ day, 10+ hour ago (120+ words) US biotech major Amgen (Nasdaq: AMGN) has announced the retirement of Peter Griffith, who has served as the company's executive vice president and chief financial officer since 2020. This article is accessible to registered users, to continue reading please register for…...
Series C to fund Accro Bioscience's mid-stage trial
5+ day, 9+ hour ago (122+ words) Accro Bioscience, a Chinese biotech developing novel therapeutics that target molecular mechanisms of regulatory cell death for immune-mediated diseases, has announced the closing of its $50 million Series C financing. This article is accessible to registered users, to continue reading please…...
New data support early use of Ingrezza in mild tardive dyskinesia
5+ day, 12+ hour ago (91+ words) This article is accessible to registered users, to continue reading please register for free." A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a…...
Roche launches 7-minute cancer shot in India
6+ day, 9+ hour ago (120+ words) Swiss pharmaceutical giant Roche (ROG: SIX) has introduced a ground-breaking cancer therapy in India: a subcutaneous (SC) injection of atezolizumab, designed to be administered in just seven minutes. This article is accessible to registered users, to continue reading please register…...
New FDA approval for Genentech's Tecentriq
6+ day, 10+ hour ago (91+ words) This article is accessible to registered users, to continue reading please register for free." A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a…...